MFS
Mirabella Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,487
| Closed | -$205K | – | 196 |
|
|
2024
Q2 | $205K | Buy |
+2,487
| New | +$205K | 0.01% | 390 |
|
|
2023
Q2 | – | Sell |
-25,652
| Closed | -$1.33M | – | 493 |
|
|
2023
Q1 | $1.33M | Sell |
25,652
-8,232
| -24% | -$427K | 0.2% | 91 |
|
|
2022
Q4 | $3.51M | Buy |
33,884
+30,940
| +1,051% | +$3.2M | 0.31% | 57 |
|
|
2022
Q3 | $250K | Sell |
2,944
-3,416
| -54% | -$290K | 0.03% | 248 |
|
|
2022
Q2 | $527K | Buy |
+6,360
| New | +$527K | 0.05% | 237 |
|
|
2021
Q1 | – | Sell |
-5,257
| Closed | -$461K | – | 288 |
|
|
2020
Q4 | $461K | Buy |
+5,257
| New | +$461K | 0.06% | 173 |
|